Technical Analysis for OGEN - Oragenics, Inc.
|Grade||Last Price||% Change||Price Change|
OGEN closed down 1.0 percent on Wednesday, January 16, 2019, on 1.42 times normal volume. It was able to find support at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
|Weak or Absent||Down||Up||Up|
|See historical OGEN trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 16||200 DMA Resistance||Bearish||0.00%|
|Jan 16||50 DMA Support||Bullish||0.00%|
|Jan 16||Wide Bands||Range Expansion||0.00%|
|Jan 16||Upper Bollinger Band Touch||Strength||0.00%|
|Jan 15||50 DMA Support||Bullish||-1.00%|
|Jan 15||MACD Bullish Centerline Cross||Bullish||-1.00%|
|Jan 14||50 DMA Support||Bullish||2.06%|
|Jan 11||200 DMA Resistance||Bearish||-1.00%|
|Jan 11||Upper Bollinger Band Touch||Strength||-1.00%|
|Jan 10||Crossed Above 20 DMA||Bullish||-5.71%|
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Oragenics, Inc., a healthcare company, engages in the discovery, development, and commercialization of various technologies associated with oral health, antibiotics, and other general health benefits in the United States and internationally. It develops ProBiora3, an oral care probiotics technology for oral health, teeth whitening, and breath freshening for humans and pets. The company's ProBiora3 products include flavored probiotic tablets, such as EvoraPlus for daily use by adults and EvoraKids for daily use by children after brushing their teeth; EvoraPet for companion pets, including cats and dogs; and EvoraPro, a professional strength version of EvoraPlus. Its product pipeline consists of LPT3-04, a naturally occurring compound for weight loss; SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay; and MU1140-S, an antibiotic product candidate in preclinical testing for healthcare-associated infections. Oragenics, Inc. offers its ProBiora3 products through direct-to-consumer channels, professional offices, and private label partnerships. The company was formerly known as Oragen, Inc. The company was founded in 1996 and is headquartered in Tampa, Florida.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more OGEN news...
|52 Week High||4.2|
|52 Week Low||0.38|
|200-Day Moving Average||1.0552|
|50-Day Moving Average||0.9546|
|20-Day Moving Average||0.9|
|10-Day Moving Average||0.9374|
|Average True Range||0.1046|
|Chandelier Exit (Long, 3 ATRs )||0.7962|
|Chandelier Exit (Short, 3 ATRs )||1.0138|
|Upper Bollinger Band||1.0372|
|Lower Bollinger Band||0.7628|
|Percent B (%b)||0.83|
|MACD Signal Line||-0.0116|
|Market Cap||48.77 Million|
|Num Shares||49.3 Million|
|Price-to-Earnings (P/E) Ratio||-6.23|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||1.23|
|Resistance 3 (R3)||1.24||1.18||1.19|
|Resistance 2 (R2)||1.18||1.12||1.17||1.18|
|Resistance 1 (R1)||1.08||1.08||1.05||1.07||1.16|
|Support 1 (S1)||0.92||0.96||0.89||0.91||0.82|
|Support 2 (S2)||0.86||0.92||0.85||0.80|
|Support 3 (S3)||0.76||0.86||0.79|
|Support 4 (S4)||0.75|